Fundraising Fox
SI-BONE
NASDAQ: SIBNSan Jose, US · Delaware corporation · 3 known investors
Find your way into SI-BONE
Sign up to see every warm intro you have to SI-BONE
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SI-BONE team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SI-BONE develops medical devices for treating sacroiliac (SI) joint dysfunction and chronic low back pain, targeting patients and physicians. Its main offering is a minimally invasive implant system used for SI joint fusion surgery.
Founders & leadership
Board
Investors · 3
How we know: Arboretum Ventures's portfolio page · the S-1 prospectus · Not right? Tell us
How we know: Montreux Equity Partners's portfolio page · the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$20M disclosed across 1 of 2 rounds · 2014–2016
▶$20MraisedJun 2016 · 9 investors · OtherRule 506(b)
- Jeffrey W. DunnExecutive Officer, Director
- Mark ReileyDirector
- Timothy E. DavisDirector
- John G. FreundDirector
- David BonitaDirector
- Karen A. LicitraDirector
- Laura FrancisExecutive Officer
- Robert E. JohnsonExecutive Officer
- Keith C. ValentineDirector
- Gregory K. HinckleyDirector
- Offering amount
- $21M
- Amount sold
- $20M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$33MofferedMay 2014 · 13 investors · OtherRule 506(b)
- Jeffrey DunnExecutive Officer, Director
- Greg HinckleyDirector
- John FreundDirector
- John SavareseDirector
- Ted DavisDirector
- Dan MurrayExecutive Officer
- Mark A. ReileyDirector
- Offering amount
- $33M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
In the news
Frequently asked questions
- What does SI-BONE do?
- SI-BONE develops medical devices for treating sacroiliac (SI) joint dysfunction and chronic low back pain, targeting patients and physicians. Its main offering is a minimally invasive implant system used for SI joint fusion surgery.
- Who founded SI-BONE?
- SI-BONE was founded by Mark Reiley.
- Who are SI-BONE's investors?
- SI-BONE's investors include Arboretum Ventures, Montreux Equity Partners, OrbiMed.
- How much funding has SI-BONE raised?
- SI-BONE has disclosed $20M raised across 1 of its 2 known rounds.
- Where is SI-BONE headquartered?
- SI-BONE is headquartered in San Jose, US.